MedTrace Logo

Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation

NCT03246607 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2019-07-02

No results posted yet for this study

Summary

This study evaluates the validity of an intravascular continuous glucose monitoring microdialysis probe, and compares the values to routinely inserted cerebral glucose microdialysis to evaluate the hypothesised relationship between intracranial and intravascular glucose levels.

Conditions

Interventions

DEVICE

MicroEye & ContinuMon

Continuous intravascular glucose monitoring using MicroEye/ContinuMon system, peripherally inserted via a peripheral venous catheter.

Sponsors & Collaborators

  • Probe Scientific Limited

    collaborator INDUSTRY

  • Dr Andrew Stevens

    lead OTHER

Principal Investigators

  • Ari Ercole, PhD · Lecturer and Consultant Anaesthetist

  • Peter Hutchinson, PhD · NIHR Research Professor at the Department of Clinical Neurosciences

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-26
Primary Completion
2020-08-02
Completion
2020-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03246607 on ClinicalTrials.gov